Evaluation
*
HighAbove AverageAverageBelow AverageLow
Amy Goodrich, MSN, CRNP
Deborah M. Stephens, DO
*
Strongly AgreeAgreeNeutralDisagreeStrongly Disagree
Assess risk and monitor response to treatment by combining classic leukemia staging methods with novel pathology biomarkers and prognostic factors
Discuss strategies for managing side effects of novel therapies, as well as preventing infections
Describe best practices for optimizing selection and sequencing of treatments in the upfront and relapsed/refractory settings
Explain the role of the Advanced Practitioner as a member of the collaborative practice team in caring for patients with CLL through the trajectory of their illness
*
Strongly AgreeAgreeNeutralDisagreeStrongly Disagree
This activity met my educational needs, expectations, and objectives
This activity was relevant to my practice
I feel confident treating patients in my practice based on this activity
This activity rates highly in comparison with other CE/CME activities in which I have participated in the last 12 months
The presentation was scientifically sound and free of commercial bias or influence
*
*
*
*
*